Exhibit 23.1
![](https://capedge.com/proxy/S-8/0001104659-24-116855/tm2428019d1_ex23-1img001.jpg)
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the registration statement on Form S-8 of Milestone Pharmaceuticals Inc. of our report dated March 21, 2024, relating to the consolidated financial statements, which appears in Milestone Pharmaceuticals Inc.’s Annual Report on Form 10-K for the year ended December 31, 2023.
/s/PricewaterhouseCoopers LLP
Montréal, Canada
November 12, 2024
PricewaterhouseCoopers LLP
1250 René-Lévesque Boulevard West, Suite 2500, Montréal, Quebec, Canada H3B 4Y1
T: +1 514 205 5000, F: +1 514 876 1502, Fax to mail: ca_montreal_main_fax@pwc.com, www.pwc.com/ca
“PwC” refers to PricewaterhouseCoopers LLP, an Ontario limited liability partnership.